Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than any change to the clinical trial record content.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision tag updated to v3.5.0; the v3.4.3 tag has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a system version update with no visible impact on trial information or user-facing features.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page header revision label was updated from v3.4.1 to v3.4.2 (v3.4.1 removed).SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.